Articles & Research
from hVIVO

World-leading Expertise in Challenge Studies Supports the Successful Delivery of a Large-scale Outpatient Vaccine Study in Healthy Participants.

Assessing Immunomodulators in Human Challenge Studies Insights from Wild-Type Influenza Infections in Healthy Adults and Rhinovirus Infections in Patients with Asthma

Isolation, Production and Validation of the First GMP RSV-B Virus for Use in Controlled Human Infection Studies

Cold Perception as A Key Endpoint in Human Challenge Trials with Respiratory Viruses

Cold Perception As a Key Endpoint in Human Challenge Trials with Respiratory Viruses

Advancing Vaccine and Treatment Development

Isolation, Characterisation, GMP Production and First RSV-B Human Challenge Study

Incidental Myocarditis in Healthy Adults Following RSV Inoculation: Insights from a Decade of Controlled Human Infection Studies

Unravelling the hMPV Surge: From Media Attention to Vaccine Development

Inflammatory messaging It’s a confusing picture out there on what is really going on with hMPV infections globally currently. Since early January hMPV (or human metapneumovirus if we are to...

Scientific Paper

SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infections

Stay connected

Sign up to our emails and follow us on social media to keep up to date with hVIVO.

By clicking Sign Up you're confirming that you agree with our Privacy Policy.